EP3532468
2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH
:
EP einkaleyfi: Þýðing ekki lögð inn:
25.10.2017:
23.3.2022:
17788234.7
:
24.10.2037
:
2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES USEFUL AS INHIBITORS OF DHODH
25.10.2017
23.3.2022
:
Bayer Aktiengesellschaft:
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, DE
:
Bayer Pharma Aktiengesellschaft:
Müllerstrasse 178, 13353 Berlin, DE
:
The Broad Institute, Inc.:
415 Main Street, Cambridge, MA 02142, US
:
President and Fellows of Harvard College:
17 Quincy Street, Cambridge, MA 02138, US
:
The General Hospital Corporation:
55 Fruit Street, Boston, MA 02114, US
:
GRADL, Stefan, Nikolaus:
13156 Berlin, DE
:
NGUYEN, Duy:
10179 Berlin, DE
:
EIS, Knut:
13587 Berlin, DE
:
GÜNTHER, Judith:
13187 Berlin, DE
:
STELLFELD, Timo:
14197 Berlin, DE
:
JANZER, Andreas:
10437 Berlin, DE
:
CHRISTIAN, Sven:
10115 Berlin, DE
:
MUELLER, Thomas:
40764 Langenfeld, DE
:
EL SHEIKH, Sherif:
45481 Mülheim/Ruhr, DE
:
ZHOU, Han, Jie:
Foster City 94404, US
:
ZHAO, Changjia:
Beijing 101111, CN
:
SYKES, David Brian:
Cambridge 02141, US
:
FERRARA, Steven, James:
Cambridge, Massachusetts 02142, US
:
LIU, Kery:
Beijing 102208, CN
:
KRÖBER, Michael:
13127 Berlin, DE
:
MERZ, Claudia:
12247 Berlin, DE
:
NIEHUES, Michael:
12159 Berlin, DE
:
SCHÄFER, Martina:
13465 Berlin, DE
:
ZIMMERMANN, Katja:
40489 Düsseldorf, DE
:
NISING, Carl, Friedrich:
51381 Leverkusen, DE
:
PCT/CN2016/103643:
27.10.2016:
WO
:
201762569296 P:
6.10.2017:
US
:
EP2017077252:
25.10.2017
:
C07D 403/12, C07D 401/12, C07D 405/12, C07D 413/12, C07D 249/12, A61K 31/4196, A61P 35/02